"Hepatitis B e Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.
Concept/Terms
Hepatitis B e Antigens- Hepatitis B e Antigens
- Hepatitis Be Antigens
- Antigens, Hepatitis Be
- Be Antigens, Hepatitis
- e Antigens
- Antigens, e
- HBeAg
Below are MeSH descriptors whose meaning is more general than "Hepatitis B e Antigens".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B e Antigens".
This graph shows the total number of publications written about "Hepatitis B e Antigens" by people in Harvard Catalyst Profiles by year, and whether "Hepatitis B e Antigens" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 4 | 4 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 2 | 4 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 2 | 3 |
| 2007 | 0 | 5 | 5 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 3 | 4 |
| 2011 | 0 | 1 | 1 |
| 2012 | 3 | 1 | 4 |
| 2013 | 2 | 1 | 3 |
| 2014 | 0 | 4 | 4 |
| 2015 | 3 | 5 | 8 |
| 2016 | 0 | 4 | 4 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 2 | 3 |
| 2019 | 4 | 2 | 6 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 5 | 7 |
| 2022 | 1 | 6 | 7 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Hepatitis B e Antigens" by people in Profiles.
-
Atypical serologic profiles of hepatitis B virus infection across clinical cohorts of patients in Southwestern Nigeria. J Immunoassay Immunochem. 2023 Mar 04; 44(2):176-191.
-
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B. Antivir Ther. 2022 12; 27(6):13596535221127848.
-
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B. Liver Int. 2023 01; 43(1):77-89.
-
Clearance of Hepatitis B e Antigen in Untreated Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-analysis. J Infect Dis. 2022 11 11; 226(10):1761-1770.
-
HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapy. Hepatology. 2023 02 01; 77(2):594-605.
-
Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection. J Acquir Immune Defic Syndr. 2022 09 01; 91(1):79-84.
-
Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B. Hepatology. 2022 09; 76(3):775-787.
-
The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis B. J Infect Dis. 2022 02 01; 225(3):470-475.
-
A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection. Clin Gastroenterol Hepatol. 2023 01; 21(1):125-135.e8.
-
Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection. Emerg Microbes Infect. 2021 Dec; 10(1):37-50.